FVIII Jivi Market Size and Forecast Jivi (damoctocog alfa pegol, BAY 94-9027) is an extended half-life recombinant Factor VIII treatment for hemophilia A, competing within the broader Factor VIII (FVIII) market. The…
Behc Sirolimus Market: Size, Forecast, Drivers, and Key Trends
Sirolimus Market Size and Forecast The global Sirolimus market is a critical segment primarily focused on immunosuppression for organ transplant rejection. The market was valued at approximately USD 231.61 million in the…
Sjog Dazodalibep Market: Size, Forecast, Drivers, and Key Trends
Dazodalibep for Sjögren’s Syndrome Market Size and Forecast Dazodalibep, currently in late-stage clinical development by Amgen (formerly Horizon Therapeutics), targets Sjögren’s Syndrome (SS), a disease with high unmet need, as there are…
Viti Topical JAK Market: Size, Forecast, Drivers, and Key Trends
Vitiligo Topical JAK Inhibitors Market Size and Forecast The Vitiligo Topical JAK Inhibitors market represents a rapidly growing segment within the broader vitiligo treatment landscape. This market is primarily driven by the…
PsA Apremilast Add Market: Size, Forecast, Drivers, and Key Trends
Apremilast Market Size and Forecast in Psoriatic Arthritis (PsA) The global Apremilast market, primarily driven by its use in chronic inflammatory conditions like Psoriatic Arthritis (PsA) and psoriasis, showed a robust market…
CD Etrasimod Market: Size, Forecast, Drivers, and Key Trends
CD Etrasimod Market Size and Forecast Etrasimod (Velsipity), an oral selective sphingosine 1-phosphate (S1P) receptor modulator, is poised to capture a significant share of the Crohn’s Disease (CD) market. The overall S1P…
UC Ritlecitinib Market: Size, Forecast, Drivers, and Key Trends
UC Ritlecitinib Market Size and Forecast The market for Ritlecitinib in Ulcerative Colitis (UC) is still nascent but holds significant potential, pending regulatory approvals and clinical trial success. As an oral Janus…
AS Bimekizumab Phase Market: Size, Forecast, Drivers, and Key Trends
AS Bimekizumab Market Size and Forecast Bimekizumab (BIMZELX), developed by UCB, has gained significant traction for treating Ankylosing Spondylitis (AS), a chronic inflammatory disease. The overall Bimekizumab market was valued at USD…
RA Otilimab Market: Size, Forecast, Drivers, and Key Trends
RA Otilimab Market Size and Forecast Otilimab represents a future entrant in the lucrative Rheumatoid Arthritis (RA) therapeutics market. As a monoclonal antibody targeting granulocyte-macrophage colony-stimulating factor (GM-CSF), its market size projection…
Nipah mAb Phase 1 Market: Size, Forecast, Drivers, and Key Trends
Nipah mAb Phase 1 Market Size and Forecast The market for Nipah virus monoclonal antibodies (mAbs) is currently nascent, primarily defined by preclinical and early-stage clinical activities, specifically Phase 1 trials. Since…